Optimal prevention of late-onset cytomegalovirus (CMV) disease and other sequelae of CMV infection in organ transplant recipients.
about
Defining the risks for cytomegalovirus infection and disease after solid organ transplantation.First face composite-tissue transplant recipient successfully treated for cytomegalovirus infection with preemptive valganciclovir treatment.Six months anti-viral prophylaxis significantly decreased cytomegalovirus disease compared with no anti-viral prophylaxis following renal transplantation.
P2860
Optimal prevention of late-onset cytomegalovirus (CMV) disease and other sequelae of CMV infection in organ transplant recipients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Optimal prevention of late-ons ...... n organ transplant recipients.
@en
Optimal prevention of late-onset cytomegalovirus
@nl
type
label
Optimal prevention of late-ons ...... n organ transplant recipients.
@en
Optimal prevention of late-onset cytomegalovirus
@nl
prefLabel
Optimal prevention of late-ons ...... n organ transplant recipients.
@en
Optimal prevention of late-onset cytomegalovirus
@nl
P356
P1476
Optimal prevention of late-ons ...... n organ transplant recipients.
@en
P2093
Nina Singh
P304
296-7; author reply 297
P356
10.1086/589577
P407
P577
2008-07-01T00:00:00Z